Suggestions
MASc Michael W. Freeman
Equity Research at Raymond James - Healthcare, Biotechnology & Synthetic Biology
Michael W. Freeman, MASc, is an Associate Analyst in Equity Research at Raymond James Ltd., specializing in healthcare, biotechnology, and synthetic biology.12 He joined Raymond James in 2019 and was promoted in 2024 to lead Canadian coverage of healthcare services, biotechnology, medical technology, and pharmaceuticals.1
Prior to his role at Raymond James, Freeman worked as an equity research associate covering healthcare and biotechnology at a boutique investment bank in Toronto.1 He also has experience as a process engineer at WSP Global, an international strategic advisory and engineering services firm.1
Freeman holds an MASc in chemical engineering from the University of Toronto, where he focused on the development of nanomedicines for cancer treatment.1 He also has a BASc in chemical engineering from Queen's University, with a focus on biological engineering and process chemistry.1
